ImmunoScore Signature

Yuming Jiang, Qi Zhang, Yanfeng Hu, Tuanjie Li, Jiang Yu, Liying Zhao, Gengtai Ye, Haijun Deng, Tingyu Mou, Shirong Cai, Zhiwei Zhou, Hao Liu, Guihua Chen, Guoxin Li, Xiaolong QiAnnals 2016 · DOI

Abstract

The ISGC classifier could effectively predict recurrence and survival of GC, and complemented the prognostic value of the TNM staging system. Moreover, the ISGC might be a useful predictive tool to identify stage II and III GC patients who would benefit from adjuvant chemotherapy.
BibTeX
@article{jiang2016immunoscore,
  author = {Yuming Jiang and Qi Zhang and Yanfeng Hu and Tuanjie Li and Jiang Yu and Liying Zhao and Gengtai Ye and Haijun Deng and Tingyu Mou and Shirong Cai and Zhiwei Zhou and Hao Liu and Guihua Chen and Guoxin Li and Xiaolong Qi},
  title = {{ImmunoScore Signature}},
  journal = {Annals},
  year = {2016},
  doi = {10.1097/sla.0000000000002116},
}

Loading related content...

Figure